Evaluation of two transposases for improving expression of recombinant proteins in Chinese hamster ovary cell stable pools by co‐transfection and supertransfection approaches
Biotechnology Progress · 2025
DOI: 10.1002/btpr.3496 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Progress, 2025. Verfasst von Melina Lenser und 3 weiteren Autor:innen. Beteiligte Einrichtung: Bioprocess Development, Technical Operations, Denali Therapeutics, Inc., South San Francisco, California, USA. Hauptthemen laut MEDLINE: Recombinant Proteins, Transfection, Transposases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Transposons are genetic elements capable of cutting and pasting genes of interest via the action of a transposase and offer many advantages over random or targeted integration of DNA in the creation of Chinese hamster ovary (CHO) cell lines for recombinant protein expression. Unique transposases have different recognition sites, allowing multiple transposases to be co‐transfected together. They also allow for supertransfection (transfection on a previously transfected pool or cell line) with a second transposase to integrate additional copies of the same gene or an additional gene without disruption of the previously integrated DNA which to our knowledge has not been previously described in literature. Two fluorescent proteins, EGFP and tagRFP657, were either co‐transfected or supertransfected into CHO cells using two unique transposases and showed high expression efficiency with similar expression levels (measured as mean fluorescence intensity), regardless of whether the genes were co‐transfected or supertransfected onto an existing stable pool. Additionally, dual selection of the genes, both in the absence of L‐glutamine and the presence of puromycin, led to higher expression levels than single selection alone. These results demonstrate that supertransfection using unique transposases could be a useful strategy for increasing titers of existing cell lines or for overexpressing helper (non‐therapeutic) genes to improve expression and/or product quality of existing pools and cell lines, potentially saving significant time and resources.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bioprocess Development, Technical Operations, Denali Therapeutics, Inc., South San Francisco, California, USA.
- Discovery Biology, Denali Therapeutics, Inc., South San Francisco, California, USA.
ORCID-Profile: Yashas Rajendra
Zitieren
APA
Lenser, M., Ngo, H. G., Sarrafha, L., & Rajendra, Y. (2025). Evaluation of two transposases for improving expression of recombinant proteins in Chinese hamster ovary cell stable pools by co‐transfection and supertransfection approaches. Biotechnology Progress. https://doi.org/10.1002/btpr.3496
Vancouver
Lenser M, Ngo HG, Sarrafha L, Rajendra Y. Evaluation of two transposases for improving expression of recombinant proteins in Chinese hamster ovary cell stable pools by co‐transfection and supertransfection approaches. Biotechnology Progress. 2025. doi:10.1002/btpr.3496
BibTeX
@article{Lenser2025,
author = {Lenser, Melina and Ngo, Hanh Giai and Sarrafha, Lily and Rajendra, Yashas},
title = {Evaluation of two transposases for improving expression of recombinant proteins in Chinese hamster ovary cell stable pools by co‐transfection and supertransfection approaches},
journal = {Biotechnology Progress},
year = {2025},
doi = {10.1002/btpr.3496}
}
EUVIMED